echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > Drug Des Devel Ther: A comparison of nausea and vomiting caused by the prevention of cesarean cessis by the right-hand metomymedine and Meda-Jiang: randomized controlled trials

    Drug Des Devel Ther: A comparison of nausea and vomiting caused by the prevention of cesarean cessis by the right-hand metomymedine and Meda-Jiang: randomized controlled trials

    • Last Update: 2020-07-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    !---- Background and Purpose This study aims to compare the efficacy of right-hand metamine and PONV caused by the prevention of mamma vomiting (PONV) caused by the prevention of cesarean cesareenmethod classed ASA as I/II, age 20 to 40 years old, 105 cases of post-section al-C section of epidural saes perjury, randomly divided into right-hand Metumingroup (D group, n-35), Meda-Lun group (M group, n-35) and control group (Group C, n-35)the fetus is given an intrauterine injection of 250 ?g xinmatomime immediately after delivery, and the vein drip sphenosis is 5 unitsat the same time D veins were given 1 sg/kg right metamine, M group gave midazolam 0.02 mg/kg, and Group C gave physiological saline 20mLrecorded other adverse reactions caused by PONV, shinma,resy, etc.), patient satisfaction, sedative score (OAA/S), and hemodynamic parametersThe incidence of PONV in group D and M was significantly lower ingroup D and Group M (Group D, Group M and Group C were 6%, 17% and 71%, respectively, and P-lt;0.05)the sedative scores (OAA/S) in group D and M were significantly higherGroup D (Group D, Group M and Group C were 1.62 to 0.28, 1.75 to 0.31 and 1.00 to 0.00, P-lt;0.05, respectively)patient satisfaction in Group D and M was significantly higher than in Group C (94%, 69% and 46% in Group D, 69% and 46%, respectively, p-lt;0.05)patient satisfaction in Group D was higher than in Group M (94% vs 69%, P-lt;0.05)concluded that intravenous right metormiadin (1?g/kg) and medaquin (0.02 mg/kg) had the same effect on PONV to prevent xinmatoma, and the satisfaction of patients in the right metoric group was better than that of the medaquin
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.